Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for Cutaneous T-cell lymphoma

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

    Rochester, MN

  3. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

    Rochester, MN

  4. Cutaneous Lymphoma Database

    Scottsdale/Phoenix, AZ

  5. Cutaneous Lymphoma Biobank Study

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer